Greg Harrison
Stock Analyst at Scotiabank
(1.81)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics | Maintains: Sector Outperform | 30 31 | 17.29 | 79.29% | 6 | Aug 7, 2025 | |
OCUL Ocular Therapeutix | Maintains: Sector Outperform | 22 20 | 12.56 | 59.24% | 2 | Aug 6, 2025 | |
BBIO BridgeBio Pharma | Maintains: Sector Outperform | 55 57 | 48.24 | 18.16% | 7 | Aug 6, 2025 | |
VRTX Vertex Pharmaceutica... | Maintains: Sector Perform | 442 438 | 374.47 | 16.97% | 7 | Aug 5, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Sector Outperform | 342 450 | 434.89 | 3.47% | 6 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 71 65 | 35.1 | 85.19% | 7 | Jul 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 9 4 | 2.93 | 36.52% | 8 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 11 | 1.74 | 532.18% | 1 | Jul 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 32 35 | 11.39 | 207.29% | 2 | Jul 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 321 315 | 300.44 | 4.85% | 4 | Jun 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 65 55 | 20.18 | 172.55% | 3 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 36 37 | 21.23 | 74.28% | 6 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 41 26 | 13.35 | 94.76% | 6 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 28 20 | 23.87 | -16.21% | 4 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 4 2 | 1.35 | 11.11% | 3 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Sector Outperform | 40 | 17.16 | 133.1% | 5 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 73 75 | 58.61 | 27.96% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 18 | 10.28 | 75.1% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 89 91 | 10.75 | 746.51% | 2 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 13.14 | -8.68% | 3 | May 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 2 | n/a | n/a | 1 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 13.2 | 195.45% | 1 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 15 | 2.2 | 581.82% | 2 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | 4.13 | -27.36% | 1 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 1.51 | 4535.76% | 1 | Sep 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 20 | 3.49 | 473.07% | 2 | Sep 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 8 | 30 | -73.33% | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 39.95 | -54.94% | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 25 7 | n/a | n/a | 4 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 54 | 15.81 | 241.56% | 1 | Mar 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 270 90 | 22.48 | 300.36% | 2 | Mar 14, 2022 |